Abstract Library

#3737 The use of somatostatin analogues in a pregnant patient with gastric NET

Introduction: The question of the use of somatostatin analogues (ASS) during pregnancy remains open and requires further clarifications and observations, but based on the facts already known to us, we can suggest that, despite the fact that there are currently no adequate well-designed and well-controlled studies evaluating the use of ASS in pregnant women, there is enough data on a limited number of patients indicating on the absence of undesirable effects of ASS on the course of pregnancy or the health of the fetus/newborn.

Conference:

Presenting Author: Androsova A

Authors: Androsova A, Orlova R, Ivanova A, Belyak N, Kutukova S,

Keywords: somatostatin analogues, Pregnancy, Neuroendocrine tumor,

#3365 Clinical and epidemiological features of neuroendocrine tumors of the gastrointestinal tract based on a single-center register

Introduction: The analysis of patients from the register of patients with NET, which was created on the basis of the Saint Petersburg State Healthcare Institution «City Clinical Oncology Center», in 2015, was analysed.

Conference:

Presenting Author:

Authors: Androsova A, Orlova R, Ivanova A, Belyak N, Kutukova S,

Keywords: neuroendocrine tumor, clinical features, register,

#3306 Secondary debulking of renal neuroendocrine tumor

Introduction: We presented a case of 54-year-old woman with anamnesis of left nefrectomy due to tumor of left kidney in august 2006. Histology showed well-differentiated neuroendocrine tumor of kidney (renal carcinoid tumor). MAI (mitotic activity index) were less then 1mf/10HPF. Imunohostechemistry examination showed positive of cytokeratins, chromogranin A, synaptofyzin. One metastatic lymph node was captured. Final stage of tumor was T1N1Mx. Patient was regularly followed in oncological ambulance.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Nosáková L

Authors: Nosakova L, Pindura M, Kyčina R, Vojtko M, Bánovčin P,

Keywords: renal neuroendocrine tumor, debulking, somatostatin analogues,

#2996 A Head-to-Head Comparison between Two Software Packages for Hybrid Dosimetry after PRRT

Introduction: The number of dosimetry studies after PRRT is increasing, yet different methodologies are used which challenge comparison or pooling of results.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Huizing D, Peters S, Versleijen M, Martens E, Verheij M,

Keywords: dosimetry, PRRT, quantification,

#1202 Role of Amplifications in the PIK3/Akt/mTOR-Pathway in Neuroendocrine Tumors of the Small Intestine

Introduction: Amplifications in the PIK3/Akt/mTOR pathway can lead to increased proliferation and reduced apoptosis, resulting in the development of various cancers. Recently, amplifications of Akt1/2, PDGFRα/β and mTOR in small intestine neuroendocrine tumors (siNET) have been shown.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Hoffmeister M, Sperveslage J, Anlauf M, Petersen K, Gress T,

Keywords: NET, gene amplification, mTOR pathway,